Allianz Global Investors Fund - Allianz Global Equity Unconstrained W9 EURRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 15.0 | 20.1 | -16.8 | 23.7 | 2.2 | |
+/-Cat | -8.7 | 5.6 | 1.3 | 7.7 | -4.3 | |
+/-B’mrk | - | 2.1 | 2.2 | 1.4 | -4.8 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 02/05/2024 | EUR 184053.43 | |
Day Change | - | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | LU1780482011 | |
Fund Size (Mil) 03/01/2024 | EUR 472.55 | |
Share Class Size (Mil) 30/04/2024 | EUR 71.23 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.74% |
Investment Objective: Allianz Global Investors Fund - Allianz Global Equity Unconstrained W9 EUR |
Long-term capital growth by investing in global equity markets to achieve a concentrated equity portfolio with a focus on stock selection. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Tobias Kohls 01/02/2021 | ||
Christian Schneider 19/12/2008 | ||
Inception Date 15/03/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR EUR | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Global Equity Unconstrained W9 EUR | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Corpay Inc | Technology | 4.58 |
Thermo Fisher Scientific Inc | Healthcare | 4.38 |
Assa Abloy AB Class B | Industrials | 4.14 |
Roper Technologies Inc | Technology | 4.14 |
Visa Inc Class A | Financial Services | 4.11 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Global Equity Unconstrained W9 EUR |